FDA Denies MDMA-Assisted therapy
What went wrong and what does it mean going forward for other drugs in clinical trials? Plus, a bit about politics, and the FDA approves Neffy for anaphylaxis
Photo credit: Shutterstock
Hello and welcome back readers. It’s been a long time since we posted an article. We recently posted our first podcast in several months—catch up here if you missed it.
Yes, a lot has changed since we recorded that podcast in July. President Joe Biden officially dropped out of the race following his disastrous June debate perf…
Keep reading with a 7-day free trial
Subscribe to Neural Pharm to keep reading this post and get 7 days of free access to the full post archives.